Stereotaxis Inc (STXS)

Currency in USD
1.360
-0.030(-2.16%)
Closed·
1.400+0.040(+2.94%)
·

STXS Earnings

Latest Release
May 12, 2026
EPS / Forecast
-0.06 / -0.05
Revenue / Forecast
6.29M / 8.72M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/06--/-0.050--/8.68M----Free Sign Up
2026/03-0.060/-0.0506.29M/8.72M-20%-27.87%Free Sign Up
2025/12-0.060/-0.0608.64M/9.15M0%-5.57%Free Sign Up
2025/09-0.070/-0.0607.46M/8.38M-16.67%-10.98%Free Sign Up
2025/06-0.050/-0.0708.80M/7.75M+28.57%+13.55%Free Sign Up
2025/03-0.070/-0.0707.47M/6.83M0%+9.37%Free Sign Up
2024/12-0.090/-0.0606.34M/8.08M-50%-21.53%Free Sign Up
2024/09-0.080/-0.0509.20M/7.10M-60%+29.58%Free Sign Up
2024/06-0.070/-0.0504.50M/5.63M-40%-20.07%Free Sign Up
2024/03-0.060/-0.0606.88M/7.00M0%-1.71%Free Sign Up

All numbers in USD

Stereotaxis Inc Earnings Call Summary for Q1/2026

  • Stereotaxis Q1 2026 revenue fell 27.87% below forecast to $6.3M; EPS of -$0.06 missed estimates by 20%, triggering 3.72% stock decline to $1.81.
  • Total revenue dropped 15.9% YoY due to strategic shift from Johnson & Johnson catheters to proprietary MAGiC catheter, temporarily impacting recurring revenue.
  • Operating loss widened to $6.0M from $5.9M YoY; gross margin held at 60% despite production constraints limiting new product revenue realization.
  • Company targets 500 catheters/month production by end-2026; new MAGiC catheter and Synchrony Digital Surgery Cockpit expected to drive future growth.
  • Stock trades near 52-week low of $1.74, down 18% YTD; analysts maintain $4-$5 price targets, suggesting potential 100%+ upside despite near-term challenges.
Last Updated: 2026-05-12, 05:26 p/m
Read Full Transcript

FAQ

What Is Stereotaxis's Earnings Per Share (TTM)?

The Stereotaxis EPS (TTM) is -0.245.

When Is The Next Stereotaxis Earnings Date?

Stereotaxis will release its next earnings report on Aug 11, 2026.

What Is Stereotaxis’s Revenue Forecasts For Upcoming Quarters?

Stereotaxis’s revenue forecast is 8.68M.

How Did Stereotaxis React to the Company's Latest Earnings Report?

Stereotaxis reported a -20% EPS surprise and a -27.87% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -1.600%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.